1. Home
  2. CORT

as 12-20-2024 4:00pm EST

$
-
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.

Founded: 1998 Country:
United States
United States
Employees: N/A City: REDWOOD CITY
Market Cap: 5.9B IPO Year: N/A
Target Price: $75.25 AVG Volume (30 days): 908.1K
Analyst Decision: Strong Buy Number of Analysts: 4
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 1.26 EPS Growth: 57.97
52 Week Low/High: $20.84 - $62.22 Next Earning Date: 02-13-2025
Revenue: $628,555,000 Revenue Growth: 39.67%
Revenue Growth (this year): 46.29% Revenue Growth (next year): 17.09%

CORT Daily Stock ML Predictions

Stock Insider Trading Activity of Corcept Therapeutics Incorporated (CORT)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Swisher Daniel N JR CORT Director Dec 10 '24 Sell $59.46 2,200 $130,812.00 0
Robb Gary Charles CORT Chief Business Officer Nov 22 '24 Sell $56.20 2,609 $146,625.80 20,163
Lyon Joseph Douglas CORT See Remarks Nov 22 '24 Sell $56.72 1,411 $80,031.92 8,494
Swisher Daniel N JR CORT Director Nov 11 '24 Sell $59.88 2,200 $131,736.00 0
Guyer William CORT Chief Development Officer Nov 1 '24 Sell $48.97 10,000 $489,700.00 5,796
Guyer William CORT Chief Development Officer Oct 1 '24 Sell $46.28 10,000 $462,800.00 5,796
Robb Gary Charles CORT Chief Business Officer Sep 27 '24 Sell $46.28 11,000 $509,080.00 20,163

Share on Social Networks: